As PD-L1 expression levels are associated with response to PD-1 inhibitors in other cancer types, the expression of PD-1 and PD-L1 on BCC tumor cells and intratumoral immune cells was measured in two different studies. This evidence concerns the gene PDCD1 and neoplasm.